The Effect of Computerized Vestibular Function Assessment and Training System Combined With Cognitive/Motor Dual-task
Launched by TAIPEI MEDICAL UNIVERSITY · Aug 4, 2023
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Dizziness is one of the most common complaints among older adults and often a concern within healthcare systems. It leads to distressing sensations, reduced mobility, and decreased quality of life. Dizziness is also closely associated with falls, which are a major cause of comorbidities and mortality in older adults. During clinical rehabilitation training, it has been observed that some elderly patients with vestibular dizziness often experience difficulties with speech clarity, lack of attention, poor direction control, or easy forgetfulness of rehabilitation training content. Similar obs...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Year 1 (Study A):
- • 1. Could walk more than 30 meters with or without walking aids independently.
- • 2. Able to comprehend and communicate in Mandarin or Taiwanese.
- • 3. Sufficient corrected vision that allows independent outdoor mobility.
- * Year 2 (Study B):
- • 1. Could walk more than 30 meters with or without walking aids independently.
- • 2. Able to comprehend and communicate in Mandarin or Taiwanese.
- • 3. Sufficient corrected vision that allows independent outdoor mobility.
- • 4. Healthy participants and those who have experienced dizziness or falls within the past two years.
- * Year 3 (Study C):
- • 1. Could walk more than 30 meters with or without walking aids independently.
- • 2. Able to comprehend and communicate in Mandarin or Taiwanese.
- • 3. Sufficient corrected vision that allows independent outdoor mobility.
- • 4. Willing to engage in moderate-intensity exercise for 45 minutes per session.
- • 5. Participants who have experienced dizziness or falls within the past two years.
- Exclusion Criteria:
- * Year 1 (Study A):
- • 1. Severe central or peripheral nervous system disorders.
- • 2. Participants who are blind or deaf.
- • 3. Individuals who cannot communicate or understand instructions.
- • 4. Current fractures or significant joint injuries.
- * Year 2 (Study B):
- • 1. Severe central or peripheral nervous system disorders.
- • 2. Participants who are blind or deaf.
- • 3. Individuals who cannot communicate or understand instructions.
- • 4. Current fractures or significant joint injuries.
- * Year 3 (Study C):
- • 1. Severe central or peripheral nervous system disorders.
- • 2. Participants who are blind or deaf.
- • 3. Individuals who cannot communicate or understand instructions.
- • 4. Current fractures or significant joint injuries.
About Taipei Medical University
Taipei Medical University (TMU) is a leading educational and research institution located in Taipei, Taiwan, dedicated to advancing health sciences and clinical research. Established with a focus on fostering innovation in medical education, TMU integrates comprehensive clinical training with rigorous research methodologies. The university is committed to improving patient outcomes through a strong emphasis on translational medicine and interdisciplinary collaboration. TMU's clinical trial initiatives are designed to explore new treatments and therapies, contributing to the global body of medical knowledge while adhering to the highest ethical standards and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Chen Po-Yin
Study Chair
Taipei Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported